Grifols Founding Family and Brookfield Plan to Take Drugmaker Private

1. Takeover Bid: Grifols' founding family and Brookfield are planning a joint takeover bid to acquire all shares of the Spanish drugmaker, potentially delisting it from the Spanish stock exchange and Nasdaq.
2. Valuation: The takeover bid could be worth around 5.5 billion euros ($5.95 billion).
3. Family Control: The Grifols family currently controls about 30% of the company's shares.
4. Financial Advisor: Lazard is the sole financial advisor to both parties.
5. Recent Developments: Grifols has faced criticism from short-seller fund Gotham City Research, leading to governance changes and revised leverage calculations.